ANAPTYSBIO, INC. (ANAB) Operating cash flow 2017–2026
ANAPTYSBIO, INC. (ANAB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$19.7MFY2026 · since FY2017: -$9.0M → $19.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $19.7M | +114.6% |
| FY2025 | -$135.3M | -12.0% |
| FY2024 | -$120.8M | -64.1% |
| FY2023 | -$73.6M | -60.3% |
| FY2022 | -$45.9M | -224.4% |
| FY2021 | -$14.2M | +79.6% |
| FY2020 | -$69.5M | -43.3% |
| FY2019 | -$48.5M | -149.5% |
| FY2018 | -$19.4M | -115.3% |
| FY2017 | -$9.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANAB financial trends
ANAB RevenueANAB Net incomeANAB Net marginANAB Gross profitANAB Gross marginANAB Operating incomeANAB Operating marginANAB Free cash flowANAB Capital expendituresANAB Return on equityANAB Stock buybacksANAB Dividends paidANAB Total assetsANAB Total liabilitiesANAB Shareholders’ equityANAB overview →